Trials / Recruiting
RecruitingNCT04413331
Prospective Longitudinal Cohort Study of Vasculitis Patients
Cohort Study of Vasculitis Patients: Longitudinal Study for the Assessment of Presentation, Comorbidities, Management, Outcomes and Damage
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 670 (estimated)
- Sponsor
- Assistance Publique - Hôpitaux de Paris · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
VASCO is a prospective observational cohort study which aim to describe the presentation, comorbidities, management, outcomes and damage of vasculitis patients, from the analysis of the clinical, biological and immunological data.
Detailed description
Vasculitis is a group of disorders characterized by the inflammation of blood vessels, leading to an alteration of the vascular wall. The classification of vasculitides has evolved considerably over the last few decades. In 1990, the American College of Rheumatology established a classification of the main systemic vasculitides based on clinical, biological and histological criteria. In 1994, the Chapel Hill nomenclature has been established as the reference classification system of vasculitides and vasculitides were classified according to the size of the affected vessels. The Chapel Hill nomenclature was revised in 2012, thus enabling to integrate new vasculitides and diagnostic tools. It is proposed here to conduct a non-interventional cohort study of the different forms of vasculitis, as defined in the Chapel Hill nomenclature. By collecting data from a large number of patients followed prospectively, our objective is to describe the clinical patterns of these diseases, the presentation, management, comorbidities and outcomes, and to evaluate their possible association with some immunological, genetic and molecular parameters.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Data collection | Medical data collection at M0, M3, M6, M9 and M12 then every 6 months until M60 and at each vascularitis relapse |
| OTHER | Biological samples and data collection | Biological samples at M0, M6, M12, M24 and at each relapse until M60 |
Timeline
- Start date
- 2020-07-02
- Primary completion
- 2027-07-01
- Completion
- 2032-07-01
- First posted
- 2020-06-02
- Last updated
- 2025-09-12
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04413331. Inclusion in this directory is not an endorsement.